SWISS DAYBOOK: SGS, Barry Callebaut, Roche, Sonova, Transocean

SGS SA (SGSN) reported net income of 534 million Swiss francs, in line with analyst estimates, and proposed a total dividend of 65 francs a share.

The company also said it may buy back as much as 250 million francs of shares.

EQUITIES: *Barry Callebaut (BARN) AG said sales volume rose 2.6 percent in the three months ending Nov. 30 2011 *Combining GlaxoSmithKline Plc’s Tykerb drug with Roche Holding AG’s Herceptin to treat breast cancer was almost twice as effective as single-drug therapy, according to researchers in a 23-country clinical trial. *Sonova Holding AG (SOON) shareholder Andy Rihs plans to reduce his stake in the company to 7-8 percent from 9 percent *Chevron Corp. ordered three new shallow-water drilling rigs from Transocean Ltd. (RIGN) for Thailand exploration projects *Galenica (GALN) AG said 2011 sales rose 2.6 percent to 3.19 billion francs *Komax (KOMN) Holding AG said full-year revenue climbed 9 percent to around 370 million francs *Martin Schaufelberger was named new chief executive of Coltene (CLTN) Holding AG *Aryzta AG (ARYN) applied to the Irish Stock Exchange for the listing of 4.2 million registered shares *Implenia AG (IMPN) won an order to build the tallest building in Zug, Switzerland

ECONOMY: *Switzerland sells three-month bills today

MARKETS: *The benchmark SMI gained 0.6 percent to 6,031.24 *The SPI increased 0.5 percent to 5,440.51 *The Stoxx Europe 600 Index advanced 0.8 percent to 251.12 *The MSCI Asia-Pacific Index rose 1.7 percent by 7:36 a.m. Swiss time *Euro-franc traded at 1.2101 at 7:37 a.m. Zurich time

To contact the reporter on this story: Klaus Wille in Zurich at kwille@bloomberg.net

To contact the editor responsible for this story: Craig Stirling at cstirling1@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.